Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualization of abnormal structures or lesions in various parts of the body including the CNS. In June 2009, INNOPHARMAX had been granted the product license from DOH to market GADOSCAN® in Taiwan.
Ms. Christine Chang
INNOPHARMAX is a specialty pharmaceutical company focused in the treatment of infectious diseases,immunology and oncology via DDS technology to improve safety & effectivene of currently available drugView profile
Clients in focus...